Visit Health looks to raise USD 10 mn in Series-A funding

Health tech start-up Visit Health is looking to raise around USD 10 million in a Series-A funding to finance its expansion, including increasing number of its empanelled doctors, hospitals, pharmacies and pathological labs, according to a top company official.

The company, an artificial intelligence-based health tech app platform offering preventive and curative, primary healthcare solutions, has already raised a total funding of USD 1.4 million and is backed by investors, including MapmyIndia, Snapdeal co-founders Kunal Bahl and Rohit Bansal, and Hetero Drugs Director Murali Krishna.

Visit Health Pvt Ltd co-founder and Head of Product Anurag Prasad said the company also plans to expand its offering by launching innovative insurance products and geographical footprint across India.

"We are looking towards raising a Series-A funding of around USD 10 million and this will be deployed in expanding reach by increasing our distribution network," Prasad told PTI.

Elaborating on the company's future plans, he said, "We are looking to aggressively enhance delivery by expanding the network of empanelled doctors, hospitals, pharmacies and pathological labs and reach by appointing new distributors network, partnering with top digital platforms."